Single-Cell Analysis how to video 👇 Access over 1,400 single-cell datasets using #PandaOmics today. #TargetDiscovery #Datasets #PharmaAI
PandaOmics
Biotechnology Research
Cambridge, Massachusetts 3,685 followers
Artificial Intelligence tool for OMICS Data Analysis, Pathway Analysis and Visualization, Target ID, Drug ID.
About us
Are you interested in AI applications to biology? Expand your horizons of OMICs data analysis and visualization with PandaOmics. Insilico Medicine has built a SaaS software platform that leverages the power of AI algorithms to perform the following tasks: 1. OMICS Data Analysis - upload your data or work with 20 000+ manually curated datasets uploaded to the platform 2. Comprehensive Pathway Analysis and Visualization - proprietary pathway analysis approach called iPanda to infer pathway activation or inhibition 3. Target Identification - converging OMICs data input and text-based derived knowledge into actionable insights for target identification and biomarker discovery 4. Drug ID for Disease - find potential compounds active against your disease of interest ... and more! Visit our website to connect and request a demo: https://pandaomics.com/access/request_demo
- Website
-
https://insilico.com/pandaomics
External link for PandaOmics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
Updates
-
PandaOmics reposted this
Our #Panda Lean is heading to Seoul! Insilico Medicine APAC BD team and PR team Shuang (Evelynn) X. have set up an exhibition booth D11 during #BioKorea 2026, in COEX, Seoul, Republic of Korea from April 28th to 30th. We have in-live Pharma.AI platform Demo, PandaOmics Chemistry42 Generative Biologics brochure. Our Panda Lean will be the gift for attendees who have detailed discussion with us. We got a lot of attentions from the visitors, other exhibitors, especially received a lot of congratulations on our recently announced multiple collaborations with Top-tier Pharma and Biotech inside or outside of East Asia We have also scheduled partnering meeting with companies who are interested in build collaboration with us. Thank you so much for your visiting to our booth and we can keep in touch with our mutual Interest.
-
-
⏰ Happening tomorrow in Cambridge at Takeda: How AI is transforming the discovery landscape. PBSS International (Pharmaceutical and BioScience Society International) There are only 24 hours left until we kick off the PBSS symposium on "Artificial Intelligence and Machine Learning Shaping the Future of Therapeutic Drug Discovery". Please join Petrina Kamya, Ph.D. VP and Global Head of AI Platforms at Insilico Medicine, with a symposium focused on Therapeutic #DrugDiscovery, and a featured presentation as well. See the full agenda and registration details here: https://bit.ly/3OSvcUe #InsilicoMedicine #PBSS #BostonBiotech
-
-
PandaOmics reposted this
🌴 That’s a wrap on #AACR2026! A heartfelt thank you to the global #oncology community for visiting the Insilico Medicine booth and engaging so deeply with our team. From sharing insights on our latest oncology programs to demonstrating how Chemistry42 is changing #smallmolecule design and optimization, the energy this year was inspiring. Our poster sessions were a hit, and we appreciate everyone who stopped by to discuss our high-quality therapeutic programs discovered through generative AI and automation. Of course, we have to mention the "population explosion" at our booth, we officially gave out over 500 PandaOmics pandas this week. We hope your new panda friends are enjoying their new homes in labs and offices across the world. We hope to see you all again in Orlando for AACR 2027! If you didn't get a chance to connect with our BD and clinical development teams, let’s keep the momentum going. Reach out to us at bd@insilicomedicine.com to learn more about our collaborative AI innovations. Visit insilico.com for more information. #SanDiego #LifeSciences #OncologyEvents #AACR26 AACR Journals
-
-
PandaOmics reposted this
👏 FINAL Day at #AACR2026 It has been a week full of engaging conversations, oncology partnering, incredible plenary keynotes, and many visits to the Insilico Medicine poster sessions and booth (#1511 if you haven't stopped by yet!) Our team is wrapping up the final day with our last poster of the event, details below: Abstract Title: ISM1745, an MTA-cooperative PRMT5 inhibitor discovered with generative AI for the treatment of MTAP-deleted cancer https://lnkd.in/eT8-qWNv Session category: Epigenetic Modulators 2 Session title: Experimental and Molecular Therapeutics Session date & time: April 22, 2026, 9:00 AM - 12:00 PM ⚡ We are in the exhibit hall until close of show today. If you haven't stopped by to see live demos of Pharma.ai, discover our oncology program updates, or said hello to the team, today is the last day! Thank you to the AACR Journals Planning and Exhibits team for a great event. We look forward to joining #AACR2026 in Orlando, Florida next year.
-
-
Time to guess Wednesday’s Target! 🐼 ➜ A clinical “failure” turned my inhibitors into one of the most recognizable breakthroughs in pharma. 💊📈 ➜ Blocking me sustains cGMP signaling and improves blood flow in multiple vascular conditions. 🧬🩺 Which target am I? 🤔 A) PDE3 B) ACE C) PDE5 D) COX-2 #PandaOmics #TargetID #WeeklyTargets #TargetDiscovery
-
PandaOmics reposted this
Day 3 of #AACR2026 is coming to a close, and it’s been another high-energy day at booth #1511. From poster presentations and media interviews on KRAS and TEAD, to strong engagement across both our pipeline and software platforms, the momentum continues to build. 🎤 Today, our team connected with media to share how Insilico Medicine is advancing AI-powered drug discovery—from early target identification through clinical-stage programs—while continuing to scale our Pharma.AI platform. 📜 Today’s poster presentations (Poster Section 17): Abstract Title: CBLB inhibition with ISM3830, a novel AI-generated #smallmolecule, restored innate and adaptive immunity and demonstrated #antitumor activity against solid tumors in vitro and in vivo Abstract Title: ISM6210, a potent and selective AI-discovered CDK4 inhibitor for the treatment of HR+/HER2- breast cancer 🚀 Across both pipeline and software, we saw strong excitement and engagement—reinforcing the power of generative AI to transform how new medicines are discovered and developed. Thank you to everyone who stopped by to connect—we look forward to continuing the conversations. #AACR2026 #AI #DrugDiscovery #Biotech #PharmaAI #Oncology #PrecisionMedicine
-
🐼 Day 3 begins at #AACR2026, and the hall is open! PandaOmics is Insilico Medicine’s AI-driven platform for therapeutic #targetdiscovery and indication expansion. It integrates and analyzes large-scale multi-omics and biomedical datasets to help researchers to identify and prioritize disease-specific drug targets and to expand the therapeutic indications of targets of interest. Interested in learning more? Our team of experts can run a live-demo for you at booth #1511. Stop by and say hello 👋 #OmicsData #Pharmaai #InsilicoMedicine
-
PandaOmics reposted this
That's a wrap on an incredible Day 1! We spent the afternoon at a packed poster session discussing ISM6166, our novel oral pan-KRAS (ON/OFF) inhibitor. Missed us today? We will be back tomorrow. 🕘 Meet our team Tomorrow at 9:00 AM: The Insilico team will be back at Booth 1511. 🧪 Pharma.AI in Action: Come see how we’re accelerating the path from data to drug candidates in record time. ☕ Let’s Connect: Whether you want to talk pan-KRAS, Cbl-b, come by and say hello. Can’t wait to see you all for Day 2! 🧬 📩 Contact: BD@insilico.com 📍 Visit us: Booth 1511 #AACR2026 #CancerResearch #DrugDiscovery #GenerativeAI #Biotech #KRAS #InsilicoMedicine
-
PandaOmics reposted this
According to an #AACR2026 attendee who returned to our Insilico Medicine booth 1511 and grabbed more #panda giveaway, our panda is the cutest giveaway in the exhibition hall. So come to get your pandas otherwise I will bring them all to #BioKorea. Although I think this panda should has taken Tirzapatide injection or biten Foundayo pills. If you haven't grab the panda, stop by our booth and just grab it. No need to fill a survey (we will print a QR code with Labubu raffle next time). Besides panda giveaway we have our Chemistry42 application scientist Haining Wang can conduct Chemistry42 . I can show PandaOmics and PandaClaw and you will love it. We Also have 3 poster sessions: CDK4 and CBLB on April 21st 9AM to 12PM, section 17 (both!) and PRMT5 on April 22nd 9AM to 12PM. Enjoy your #AACR annual meeting and come to meet us! #cancerresearchsavelives Daniel Miller Andrew Miller Korda, MSHC Fifi Pan Alex Zhavoronkov
-